Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Problem Solving Treatment with or without duloxetine for major depressive disorder in primary care
2008-005695-27Phase 4Active
- Sponsor
- Eli Lilly and Company
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of duloxetine in major depressive disorder (MDD) (2 arms), sponsored by Eli Lilly and Company. Started Sep 2008; status: active.
02
Drugs
duloxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2008-005695-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005695-27.